Physician
Jivani, Aslam
Jivani, Aslam was paid $1.30M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoJIVANI, ASLAM
ELMHURST, NY 11373
ELMHURST, NY 11373
33aNPI1750392411assigned 08/10/2006
33bProvider typeInternal Medicine Physician
28Total paid$1.30M
24GClaims49,379
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#222 of 6,049
Median peer was paid$11K
This provider vs. median115×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,432 | $186K | |
| 2019 | 8,073 | $257K | |
| 2020 | 4,994 | $117K | |
| 2021 | 9,107 | $218K | |
| 2022 | 8,146 | $171K | |
| 2023 | 7,621 | $199K | |
| 2024incomplete | 5,006 | $150K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 7,596 | 7,025 | $315K |
| 94060 | 15% | 7,059 | 6,797 | $199K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 2,963 | 2,827 | $150K |
| 94729 | 8.4% | 3,757 | 3,701 | $109K | |
| 94726 | 8.1% | 3,751 | 3,693 | $105K | |
| 99243 | 5.6% | 769 | 686 | $73K | |
| 94010 | 3.7% | 2,860 | 2,808 | $49K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.9% | 171 | 166 | $37K |
| 94621 | 2.8% | 516 | 507 | $37K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 293 | 289 | $24K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 682 | 469 | $22K |
| 95921 | 1.2% | 338 | 332 | $16K |
53 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 1,293 | $15K |
| 92552 | 1.1% | 705 | $15K | |
| 91320 | 1.1% | 341 | $14K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.0% | 1,167 | $13K |
| 90674 | 1.0% | 599 | $13K | |
| 95117 | <1% | 1,095 | $9K | |
| 93000 | <1% | 919 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 404 | $8K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 103 | $7K |
| 93922 | <1% | 73 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 442 | $4K |
| 90480 | <1% | 331 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,280 | $4K |
| 0134A | <1% | 208 | $4K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 12 | $4K |
| 76536 | <1% | 53 | $3K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 36 | $3K |
| 96401 | <1% | 80 | $3K | |
| 95922 | <1% | 71 | $2K | |
| 90694 | <1% | 379 | $2K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 198 | $2K |
| 95115 | <1% | 240 | $2K | |
| 94664 | <1% | 220 | $2K | |
| 90661 | <1% | 70 | $2K | |
| 95012 | <1% | 76 | $1K | |
| 90653 | <1% | 159 | $1K | |
| 96127 | <1% | 438 | $1K | |
| 92511 | <1% | 15 | $1K | |
| 90750 | <1% | 17 | $857.11 | |
| 90686 | <1% | 43 | $831.58 | |
| 99490 | Ccm add 20min | <1% | 138 | $666.90 |
| 0012A | <1% | 18 | $619.76 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 33 | $491.35 |
| 0064A | <1% | 14 | $436.40 | |
| 0011A | <1% | 15 | $407.06 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 37 | $393.22 |
| 94761 | <1% | 201 | $320.89 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 3,503 | $305.68 |
| 90662 | <1% | 13 | $294.29 | |
| 99173 | <1% | 281 | $293.08 | |
| 99439 | <1% | 26 | $130.43 | |
| G0008 | Administration of influenza virus vaccine | <1% | 262 | $62.36 |
| J3535 | Drug administered through a metered dose inhaler | <1% | 53 | $58.11 |
| 99497 | <1% | 16 | $34.98 | |
| 3078F | <1% | 312 | $32.39 | |
| 3074F | <1% | 250 | $7.88 | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 28 | $0.09 |
| 1160F | 0% | 615 | $0.00 | |
| 91313 | 0% | 44 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 12 | $0.00 |
| 3008F | 0% | 480 | $0.00 | |
| 3044F | 0% | 168 | $0.00 | |
| 3048F | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.